Evidence map›Paper›PMID 31856174›Full record

ReviewPloS one2019

Gender and neglected tropical disease front-line workers: Data from 16 countries.

Erica A Shoemaker, Kelly Dale, Daniel A Cohn, Maureen P Kelly, Kathryn L Zoerhoff, Wilfrid E Batcho, Clarisse Bougouma, Georges B Nko'Ayissi, Aboulaye Meite, Benjamin Marfo and 20 more

Abstract readReview
In one paragraph

Review in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Impact of post-total thyroidectomy thyroglobulin levels on recurrence in patients with differentiated  thyroid cancer at a tertiary care center in Mexico.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Antiparasitic Effect of Stilbene and Terphenyl Compounds againstPharmaceuticals (Basel, Switzerland) · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Erica A ShoemakerRTI International, Washington, DC, United States of America.ORCID 0000-0002-9799-6021
Kelly DaleWI-HER, Vienna, Virginia, United States of America.
Daniel A CohnFHI 360, Washington, DC, United States of America.ORCID 0000-0001-7014-0031
Maureen P KellyRTI International, Washington, DC, United States of America.
Kathryn L ZoerhoffRTI International, Washington, DC, United States of America.
Wilfrid E BatchoNational Communicable Disease Control Program, Ministry of Health, Cotonou, Republic of Benin.
Clarisse BougoumaNational Neglected Tropical Disease Control Program, Disease Control Directorate, Ministry of Health, Ouagadougou, Burkina Faso.
Georges B Nko'AyissiMalaria and Neglected Tropical Diseases Sub-Department, Ministry of Public Health, Yaoundé, Republic of Cameroon.
Aboulaye MeiteNational Control Program for Preventive Chemotherapy Neglected Tropical Diseases, Ministry of Health and Public Hygiene, Abidjan, Republic of Côte d'Ivoire.
Benjamin MarfoNational Neglected Tropical Diseases Program, Ghana Health Service, Accra, Republic of Ghana.
André GoepoguiNational Onchocerciasis and Blindness and Neglected Tropical Disease Control Program, National Prevention and Community Health Directorate, Ministry of Health, Conakry, Republic of Guinea.
Marc-Aurele TelfortNational Malaria Control Program, Ministry of Public Health and Population, Port-au-Prince, Republic of Haiti.
Lita Renata SianiparSub-Directorate of Filariasis & Helminthiasis Control, Directorate of Vector Borne Disease Control, Directorate General of Communicable Disease and Environmental Health, Ministry of Health, Jakarta, Republic of Indonesia.
Mahamadou TraoreNational Schistosomiasis and Soil-Transmitted Helminths Control Program, Ministry of Health and Public Hygiene, Bamako, Mali.
Pradip RimalEpidemiology and Disease Control Division, Department of Health Services, Ministry of Health, Kathmandu, Federal Democratic Republic of Nepal.
Djibo Aichatou AlfariNTD Control Program, Directorate of the Protection of Public Health, Ministry of Public Health, Niamey, Republic of Niger.
Chukwuma AnyaikeDepartment of Public Health, Neglected Tropical Diseases Division, Federal Ministry of Health, Abuja, Federal Republic of Nigeria.
Fatou N BadianeNTD Control Program, Disease Control Directorate, Ministry of Health and Social Work, Dakar, Senegal.
Ibrahim Kargbo-LabourNeglected Tropical Diseases Programme, Disease Prevention and Control Directorate, Ministry of Health and Sanitation, Freetown, Republic of Sierra Leone.
Upendo J MwingiraNeglected Tropical Diseases Control Programme, Ministry of Health, Dar es Salaam, United Republic of Tanzania.
Marcel S AwoussiNational Neglected Tropical Disease Control Program, General Directorate of Health, Ministry of Health and Social Welfare, Lomé, Republic of Togo.
Rachel D StelmachRTI International, Washington, DC, United States of America.ORCID 0000-0002-4903-4995
Carly L SmithOffice of Infectious Diseases, US Agency for International Development, Washington, DC, United States of America.
Jennifer ArneyFHI 360, Washington, DC, United States of America.
Taroub Harb FaramandWI-HER, Vienna, Virginia, United States of America.
Diana M StukelFHI 360, Washington, DC, United States of America.
Bolivar PouFHI 360, Washington, DC, United States of America.
Lisa A RotondoRTI International, Washington, DC, United States of America.
John D KraemerRTI International, Washington, DC, United States of America.
Margaret C BakerRTI International, Washington, DC, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDelivery of preventive chemotherapy (PC) through mass drug administration (MDA) is used to control or eliminate five of the most common neglected tropical diseases (NTDs). The success of an MDA campaign relies on the ability of drug distributors and their supervisors-the NTD front-line workers-to reach populations at risk of NTDs. In the past, our understanding of the demographics of these workers has been limited, but with increased access to sex-disaggregated data, we begin to explore the implications of gender and sex for the success of NTD front-line workers. METHODOLOGY/PRINCIPAL

findingsWe reviewed data collected by USAID-supported NTD projects from national NTD programs from fiscal years (FY) 2012-2017 to assess availability of sex-disaggregated data on the workforce. What we found was sex-disaggregated data on 2,984,908 trainees trained with financial support from the project. We then analyzed the percentage of males and females trained by job category, country, and fiscal year. During FY12, 59% of these data were disaggregated by sex, which increased to nearly 100% by FY15 and was sustained through FY17. In FY17, 43% of trainees were female, with just four countries reporting more females than males trained as drug distributors and three countries reporting more females than males trained as trainers/supervisors. Except for two countries, there were no clear trends over time in changes to the percent of females trained. CONCLUSIONS/SIGNIFICANCE: There has been a rapid increase in availability of sex-disaggregated data, but little increase in recruitment of female workers in countries included in this study. Women continue to be under-represented in the NTD workforce, and while there are often valid reasons for this distribution, we need to test this norm and better understand gender dynamics within NTD programs to increase equity.

Indexed as

ChemopreventionFemaleGlobal HealthHumansMaleMass Drug AdministrationNeglected DiseasesSex FactorsSexismTropical Medicine

Identifiers

PMID31856174
PMCPMC6922366

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.